Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modified Nasal High-flow Oxygen Therapy for Acute Respiratory Failure Patients Undergoing Flexible Bronchoscopy

NCT05759832 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.

NCT NCT05759832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05759832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modified Nasal High-flow Oxygen Therapy for Acute Respiratory Failure Patients Undergoing Flexible Bronchoscopy
Lead sponsor
Beijing Chao Yang Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2023
Completion date
July 30, 2025
Enrollment
160 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypoxemic respiratory failure, high-flow nasal cannula oxygen